These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 12606600

  • 1. Two novel and selective nonimidazole H3 receptor antagonists A-304121 and A-317920: II. In vivo behavioral and neurophysiological characterization.
    Fox GB, Pan JB, Radek RJ, Lewis AM, Bitner RS, Esbenshade TA, Faghih R, Bennani YL, Williams M, Yao BB, Decker MW, Hancock AA.
    J Pharmacol Exp Ther; 2003 Jun; 305(3):897-908. PubMed ID: 12606600
    [Abstract] [Full Text] [Related]

  • 2. Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects.
    Esbenshade TA, Krueger KM, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Fox GB, Faghih R, Bennani YL, Williams M, Hancock AA.
    J Pharmacol Exp Ther; 2003 Jun; 305(3):887-96. PubMed ID: 12606603
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist.
    Fox GB, Esbenshade TA, Pan JB, Radek RJ, Krueger KM, Yao BB, Browman KE, Buckley MJ, Ballard ME, Komater VA, Miner H, Zhang M, Faghih R, Rueter LE, Bitner RS, Drescher KU, Wetter J, Marsh K, Lemaire M, Porsolt RD, Bennani YL, Sullivan JP, Cowart MD, Decker MW, Hancock AA.
    J Pharmacol Exp Ther; 2005 Apr; 313(1):176-90. PubMed ID: 15608077
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist.
    Esbenshade TA, Fox GB, Krueger KM, Baranowski JL, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Pan JB, Faghih R, Bennani YL, Williams M, Hancock AA.
    Biochem Pharmacol; 2004 Sep 01; 68(5):933-45. PubMed ID: 15294456
    [Abstract] [Full Text] [Related]

  • 5. Correlation between ex vivo receptor occupancy and wake-promoting activity of selective H3 receptor antagonists.
    Le S, Gruner JA, Mathiasen JR, Marino MJ, Schaffhauser H.
    J Pharmacol Exp Ther; 2008 Jun 01; 325(3):902-9. PubMed ID: 18305012
    [Abstract] [Full Text] [Related]

  • 6. Identification and pharmacological characterization of a series of new 1H-4-substituted-imidazoyl histamine H3 receptor ligands.
    Yates SL, Phillips JG, Gregory R, Pawlowski GP, Fadnis L, Khan MA, Ali SM, Tedford CE.
    J Pharmacol Exp Ther; 1999 May 01; 289(2):1151-9. PubMed ID: 10215699
    [Abstract] [Full Text] [Related]

  • 7. Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats.
    Medhurst AD, Briggs MA, Bruton G, Calver AR, Chessell I, Crook B, Davis JB, Davis RP, Foley AG, Heslop T, Hirst WD, Medhurst SJ, Ociepka S, Ray A, Regan CM, Sargent B, Schogger J, Stean TO, Trail BK, Upton N, White T, Orlek B, Wilson DM.
    Biochem Pharmacol; 2007 Apr 15; 73(8):1182-94. PubMed ID: 17276409
    [Abstract] [Full Text] [Related]

  • 8. Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist.
    Ligneau X, Lin J, Vanni-Mercier G, Jouvet M, Muir JL, Ganellin CR, Stark H, Elz S, Schunack W, Schwartz J.
    J Pharmacol Exp Ther; 1998 Nov 15; 287(2):658-66. PubMed ID: 9808693
    [Abstract] [Full Text] [Related]

  • 9. Anxiety and cognition in histamine H3 receptor-/- mice.
    Rizk A, Curley J, Robertson J, Raber J.
    Eur J Neurosci; 2004 Apr 15; 19(7):1992-6. PubMed ID: 15078574
    [Abstract] [Full Text] [Related]

  • 10. Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.
    Gbahou F, Vincent L, Humbert-Claude M, Tardivel-Lacombe J, Chabret C, Arrang JM.
    Br J Pharmacol; 2006 Apr 15; 147(7):744-54. PubMed ID: 16432504
    [Abstract] [Full Text] [Related]

  • 11. Evidence for tolerance following repeated dosing in rats with ciproxifan, but not with A-304121.
    Pan JB, Yao BB, Miller TR, Kroeger PE, Bennani YL, Komater VA, Esbenshade TA, Hancock AA, Decker MW, Fox GB.
    Life Sci; 2006 Aug 29; 79(14):1366-79. PubMed ID: 16730751
    [Abstract] [Full Text] [Related]

  • 12. The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders.
    Parmentier R, Anaclet C, Guhennec C, Brousseau E, Bricout D, Giboulot T, Bozyczko-Coyne D, Spiegel K, Ohtsu H, Williams M, Lin JS.
    Biochem Pharmacol; 2007 Apr 15; 73(8):1157-71. PubMed ID: 17288995
    [Abstract] [Full Text] [Related]

  • 13. Differential in vivo effects of H3 receptor ligands in a new mouse dipsogenia model.
    Fox GB, Pan JB, Esbenshade TA, Bitner RS, Nikkel AL, Miller T, Kang CH, Bennani YL, Black LA, Faghih R, Hancock AA, Decker MW.
    Pharmacol Biochem Behav; 2002 Jun 15; 72(3):741-50. PubMed ID: 12175472
    [Abstract] [Full Text] [Related]

  • 14. Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weight.
    Malmlöf K, Zaragoza F, Golozoubova V, Refsgaard HH, Cremers T, Raun K, Wulff BS, Johansen PB, Westerink B, Rimvall K.
    Int J Obes (Lond); 2005 Dec 15; 29(12):1402-12. PubMed ID: 16151415
    [Abstract] [Full Text] [Related]

  • 15. Autoregulation of McA-RH7777 hepatoma cell proliferation by histamine H3 receptors.
    Davenas E, Rouleau A, Morisset S, Arrang JM.
    J Pharmacol Exp Ther; 2008 Aug 15; 326(2):406-13. PubMed ID: 18474684
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological properties and procognitive effects of ABT-288, a potent and selective histamine H3 receptor antagonist.
    Esbenshade TA, Browman KE, Miller TR, Krueger KM, Komater-Roderwald V, Zhang M, Fox GB, Rueter L, Robb HM, Radek RJ, Drescher KU, Fey TA, Bitner RS, Marsh K, Polakowski JS, Zhao C, Cowart MD, Hancock AA, Sullivan JP, Brioni JD.
    J Pharmacol Exp Ther; 2012 Oct 15; 343(1):233-45. PubMed ID: 22815533
    [Abstract] [Full Text] [Related]

  • 17. Effects of histamine H(3) receptor ligands GT-2331 and ciproxifan in a repeated acquisition avoidance response in the spontaneously hypertensive rat pup.
    Fox GB, Pan JB, Esbenshade TA, Bennani YL, Black LA, Faghih R, Hancock AA, Decker MW.
    Behav Brain Res; 2002 Apr 01; 131(1-2):151-61. PubMed ID: 11844582
    [Abstract] [Full Text] [Related]

  • 18. Anticonvulsant properties of histamine H3 receptor ligands belonging to N-substituted carbamates of imidazopropanol.
    Sadek B, Shehab S, Więcek M, Subramanian D, Shafiullah M, Kieć-Kononowicz K, Adem A.
    Bioorg Med Chem Lett; 2013 Sep 01; 23(17):4886-91. PubMed ID: 23891186
    [Abstract] [Full Text] [Related]

  • 19. Detailed pharmacological characterization of GT-2331 for the rat histamine H3 receptor.
    Ito S, Yoshimoto R, Miyamoto Y, Mitobe Y, Nakamura T, Ishihara A, MacNeil DJ, Kanatani A, Tokita S.
    Eur J Pharmacol; 2006 Jan 04; 529(1-3):40-6. PubMed ID: 16316645
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological characterization of the novel histamine H3-receptor antagonist N-(3,5-dichlorophenyl)-N'-[[4-(1H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687).
    McLeod RL, Rizzo CA, West RE, Aslanian R, McCormick K, Bryant M, Hsieh Y, Korfmacher W, Mingo GG, Varty L, Williams SM, Shih NY, Egan RW, Hey JA.
    J Pharmacol Exp Ther; 2003 Jun 04; 305(3):1037-44. PubMed ID: 12649305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.